Turkish adaptation of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) for clinical investigators
Semra Erdogan, Gulhan Orekici Temel
Çukurova Üniversitesi Tıp Fakültesi Dergisi · 2016
doi:10.17826/cutf.254165 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Purpose: The primary purpose in this study is to provide to researchers with the Turkish adaptation of GRRAS, which was initially developed for the sake of accurately and completely report reliability and agreement studies. The secondary purpose, is to set forth the rate at which GRRAS was utilized in the reliability and agreement related articles published in the scanned journals of the Turkish Medical Index since 2011. Material and Methods: GRRAS was translated into Turkish by two authors. Later on, studies published in the Turkish Medical Index since 2011 were examined in line with the determined criteria. Results: The items included in each section of the Turkish-adapted GRASS were explained. Furthermore, in consequence of the scanning of the Turkish Medical Index, it was determined that of the total 34 studies were published. All these studies were evaluated with the use of the Turkish-adaption of GRRAS and on the basis of every item included in the guide, reporting percentages were determined by years and in total. Discussion and Conclusion: It was so important for reviewers and editors to make reviews in a standardized way and also for researchers to report their studies in a standard format. [Cukurova Med J 2016; 41(4.000): 613-621]
Abstract licence: CC BY-NC-ND
References12
- 4.
- 7.
- 12.
9 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.